The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
University of Michigan Rogel Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Duke University
AstraZeneca
Essen Biotech
Eli Lilly and Company
Angiex, Inc.
Poseida Therapeutics, Inc.
MacroGenics
Unity Health Toronto
City of Hope Medical Center
Daiichi Sankyo
Takeda
Cue Biopharma
Eli Lilly and Company
Boehringer Ingelheim
HealthPartners Institute
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals
City of Hope Medical Center
MOMA Therapeutics
Mayo Clinic
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Pfizer
Dana-Farber Cancer Institute
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Actym Therapeutics, Inc.
Maastricht University Medical Center
Institut Bergonié
Day One Biopharmaceuticals, Inc.
GI Innovation, Inc.
Exelixis
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Senhwa Biosciences, Inc.